Glomerulonephritis Clinical Trials
42 clinical trials for Glomerulonephritis across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. — RECRUITING · PHASE3
- A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy — RECRUITING · PHASE2
- Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy. — RECRUITING · PHASE4
- The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland — RECRUITING · PHASE2
- AN OPEN-LABEL, NONRANDOMIZED, MULTICENTER EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF PEGCETACOPLAN IN PATIENTS WITH C3 GLOMERULOPATHY OR IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS — RECRUITING
- Artificial Intelligence Model for Renal Allograft Rejection Identification, Lesion Quantification and Rejection Risk Prediction Based on Prospective Renal Transplant Pathology and Clinical Multidimensional Data — ACTIVE_NOT_RECRUITING
- TESTING -ON Post-Trial ObservatioNal Cohort Study — COMPLETED
- Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy — NOT_YET_RECRUITING · PHASE2
- A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy — COMPLETED · PHASE1
- Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis — COMPLETED · PHASE2
- Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria — NOT_YET_RECRUITING · NA
- Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE) — COMPLETED · PHASE2
- Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study — NOT_YET_RECRUITING
- ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES — COMPLETED
- Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis — NOT_YET_RECRUITING · PHASE2
- Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency — COMPLETED · PHASE1
- Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted — COMPLETED · PHASE2
- A Study of Rituximab in Frontline Therapy for Glomerulonephritis — OTHER
- An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases — TERMINATED · PHASE2
- A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease — TERMINATED · PHASE2
- Bortezomib for Treating Glomerular Diseases — OTHER · NA
- Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria — COMPLETED
- Empagliflozin in Patients With Glomerulonephritis — COMPLETED · PHASE3
- US Time-Harmonic Elastography for the Early Detection of Childhood Glomerulonephritis — OTHER
- Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 — OTHER · PHASE1
- Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment — TERMINATED · PHASE4
- Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis — OTHER · PHASE4
- Plant Versus Animal Dietary Protein and the Effect on Proteinuria — OTHER · NA
- Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis — COMPLETED
- A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy — COMPLETED · PHASE1
- Recurrent Glomerulonephritis After Renal Transplantation — COMPLETED
- Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis — OTHER · PHASE4
- A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy — COMPLETED · PHASE4
- Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis — TERMINATED · PHASE3
- Calcitriol in the Treatment of Immunoglobulin A Nephropathy — OTHER · PHASE4
- Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor — COMPLETED · PHASE3
- The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy — COMPLETED · NA
- Lamivudine for Chronic Hepatitis B — COMPLETED · PHASE2
- Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis — COMPLETED · PHASE2
- Cyclophosphamide and Fludarabine to Treat Lupus Nephritis — COMPLETED · PHASE1
- Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis — COMPLETED · PHASE1
- Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney — COMPLETED · PHASE2
Refine this search